Table 2 Detailed antiplatelet treatment in AMI patients
|  | Overall population (%/Mean ± SD) | STEMI (%/Mean ± SD) | NSTEMI (%/Mean ± SD) |  P value |
|---|---|---|---|---|
|  | N = 40,202 | N = 30,179 | N = 10,023 | |
Antiplatelet treatment strategy (n, %) | ||||
 Aspirin loading | 25,011 (62.2%) | 19,901 (65.9%) | 5110 (51.0%) |  < 0.001 |
 P2Y12 loading | 25,557 (63.6%) | 19,993 (66.2%) | 5564 (55.5%) |  < 0.001 |
 Aspirin maintenance | 37,414 (93.1%) | 28,087 (93.1%) | 9327 (93.1%) | 0.967 |
 P2Y12 maintenance | 36,405 (90.6%) | 27,249 (90.3%) | 9156 (91.3%) | 0.002 |
 DAPT | 36,154 (89.9%) | 27,134 (89.9%) | 9020 (90.0%) | 0.811 |